International study finds insomnia, anxiety and depression very prevalent during first phase of COVID-19 pandemic
10 September 2021
Researchers are recommending public health interventions to reduce the long-term adverse outcomes associated with chronic insomnia and mental health problems.
23 November 2020
Multiple recent case reports have suggested a link between COVID-19 and Guillain-Barré syndrome (GBS), an acute, disabling, immune-mediated disorder of the peripheral nervous system. It is currently unclear whether this simply represents a chance association.
20 November 2020
The OxVent is a rapidly deployable and scalable low-cost mechanical ventilator specially designed for COVID-19, which has now been recognised as one of the best innovations of the year by the Institute of Engineering and Technology.
20 November 2020
New research into the HIV-1 virus has shed light on an important factor in the evolution of viruses, which is likely also to affect SARS-CoV-2 (the virus which causes COVID-19). This new insight could have important implications for vaccine development.
21 July 2020
Researchers at the University of Oxford are investigating the long-term health outcomes for patients who have been treated for severe COVID-19 disease in intensive care. Finding out whether these outcomes differ from those of other patients who have survived critical care will help to inform clinical practice and appropriate follow-up care.
6 July 2020
The University of Oxford's LIFE project has launched a new set of app-based training scenarios that help healthcare workers in Africa safely manage and treat cases of children with suspected COVID-19
18 June 2020
Staff at our Oxford Simulation,Teaching & Research centre (OxSTaR) helped to develop this new type of aerosol shield designed by Formula One motor racing engineers
11 June 2020
An international group of researchers led by Professor Colin Espie is investigating the impact of the COVID-19 pandemic on sleep and daily rhythms in adults.
10 June 2020
As part of the UK NIHR multi-arm, multi-stage CATALYST Trial, researchers at the University of Oxford will investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death.
29 May 2020
Researchers including Stuart McKechnie and Matthew Rowland from our Critical Care Research Group are carrying out a new drug trial aimed at treating COVID-19, funded by LifeArc.
1 May 2020
A team of our neuroimaging researchers will lead this study, which has received a grant from the University of Oxford's COVID-19 Research Response Fund.
29 April 2020
The Oxford Simulation, Teaching and Research Centre has been busier than ever during the coronavirus pandemic
7 April 2020
The NIHR Oxford Biomedical Research Centre (BRC) has allocated funding to three COVID-19 research projects in an attempt to improve treatment, understand how the virus interacts with chronic diseases, and the longer-term effects of infection on organs.
6 April 2020
NHS England has announced a programme to provide NHS staff with evidence-based digital programmes to protect their mental health during the COVID-19 response. The apps are designed to help maintain healthy sleep, and reduce anxiety.
1 April 2020
System being used in John Warin isolation ward at Oxford's John Radcliffe Hospital
20 March 2020
An interdisciplinary team of engineers and medics is addressing ways to increase the UK’s capacity for ventilator manufacture.